Global and United States Gastrointestinal Cancer Drugs Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Gastrointestinal Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type
1.4.2 Oncology
1.4.3 Radiology
1.4.4 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialized Cancer Treatment Centers
1.5.4 Clinics
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal Cancer Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal Cancer Drugs Sales 2015-2026
2.2 Global Gastrointestinal Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gastrointestinal Cancer Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Gastrointestinal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gastrointestinal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gastrointestinal Cancer Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Region (2021-2026)
3 Global Gastrointestinal Cancer Drugs Competitor Landscape by Players
3.1 Global Top Gastrointestinal Cancer Drugs Sales by Manufacturers
3.1.1 Global Gastrointestinal Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Gastrointestinal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gastrointestinal Cancer Drugs Manufacturers by Revenue
3.2.1 Global Gastrointestinal Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Gastrointestinal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Drugs Revenue in 2019
3.2.5 Global Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastrointestinal Cancer Drugs Price by Manufacturers
3.4 Global Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal Cancer Drugs Price by Application (2015-2020)
5.2 Gastrointestinal Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal Cancer Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Gastrointestinal Cancer Drugs Sales YoY Growth 2015-2026
6.1.2 United States Gastrointestinal Cancer Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Gastrointestinal Cancer Drugs Market Share in Global Market 2015-2026
6.2 United States Gastrointestinal Cancer Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Gastrointestinal Cancer Drugs Players by Sales (2015-2020)
6.2.2 United States Top Gastrointestinal Cancer Drugs Players by Revenue (2015-2020)
6.3 United States Gastrointestinal Cancer Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Gastrointestinal Cancer Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Gastrointestinal Cancer Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Gastrointestinal Cancer Drugs Price by Type (2015-2020)
6.4 United States Gastrointestinal Cancer Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Gastrointestinal Cancer Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Gastrointestinal Cancer Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Gastrointestinal Cancer Drugs Price Forecast by Type (2021-2026)
6.5 United States Gastrointestinal Cancer Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Gastrointestinal Cancer Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Gastrointestinal Cancer Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Gastrointestinal Cancer Drugs Price by Application (2015-2020)
6.6 United States Gastrointestinal Cancer Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Gastrointestinal Cancer Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Gastrointestinal Cancer Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Gastrointestinal Cancer Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
7.2 North America Gastrointestinal Cancer Drugs Market Facts & Figures by Country
7.2.1 North America Gastrointestinal Cancer Drugs Sales by Country (2015-2020)
7.2.2 North America Gastrointestinal Cancer Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
8.2 Europe Gastrointestinal Cancer Drugs Market Facts & Figures by Country
8.2.1 Europe Gastrointestinal Cancer Drugs Sales by Country
8.2.2 Europe Gastrointestinal Cancer Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gastrointestinal Cancer Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Gastrointestinal Cancer Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Gastrointestinal Cancer Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Gastrointestinal Cancer Drugs Market Facts & Figures by Country
10.2.1 Latin America Gastrointestinal Cancer Drugs Sales by Country
10.2.2 Latin America Gastrointestinal Cancer Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastrointestinal Cancer Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gastrointestinal Cancer Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country
11.2.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Amgen & Amgen Ireland
12.1.1 Amgen & Amgen Ireland Corporation Information
12.1.2 Amgen & Amgen Ireland Description and Business Overview
12.1.3 Amgen & Amgen Ireland Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Products Offered
12.1.5 Amgen & Amgen Ireland Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Corporation Information
12.2.2 Bristol-Myers Squibb Company Description and Business Overview
12.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Products Offered
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Gastrointestinal Cancer Drugs Products Offered
12.3.5 Roche Recent Development
12.4 Eli Lilly and Company
12.4.1 Eli Lilly and Company Corporation Information
12.4.2 Eli Lilly and Company Description and Business Overview
12.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Products Offered
12.4.5 Eli Lilly and Company Recent Development
12.5 Johnson & Johnson Private
12.5.1 Johnson & Johnson Private Corporation Information
12.5.2 Johnson & Johnson Private Description and Business Overview
12.5.3 Johnson & Johnson Private Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Products Offered
12.5.5 Johnson & Johnson Private Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Description and Business Overview
12.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Celgene Corporation
12.7.1 Celgene Corporation Corporation Information
12.7.2 Celgene Corporation Description and Business Overview
12.7.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Products Offered
12.7.5 Celgene Corporation Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Gastrointestinal Cancer Drugs Products Offered
12.8.5 Pfizer Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Gastrointestinal Cancer Drugs Products Offered
12.9.5 Sanofi Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis Gastrointestinal Cancer Drugs Products Offered
12.10.5 Novartis Recent Development
12.11 Amgen & Amgen Ireland
12.11.1 Amgen & Amgen Ireland Corporation Information
12.11.2 Amgen & Amgen Ireland Description and Business Overview
12.11.3 Amgen & Amgen Ireland Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Products Offered
12.11.5 Amgen & Amgen Ireland Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Gastrointestinal Cancer Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oncology
Table 5. Major Manufacturers of Radiology
Table 6. Major Manufacturers of Others
Table 7. Global Gastrointestinal Cancer Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Gastrointestinal Cancer Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Gastrointestinal Cancer Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Gastrointestinal Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Gastrointestinal Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Gastrointestinal Cancer Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Gastrointestinal Cancer Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Gastrointestinal Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Gastrointestinal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Gastrointestinal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Cancer Drugs as of 2019)
Table 17. Gastrointestinal Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Gastrointestinal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Gastrointestinal Cancer Drugs Price (2015-2020) (USD/Unit)
Table 20. Gastrointestinal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Gastrointestinal Cancer Drugs Product Type
Table 22. Date of International Manufacturers Enter into Gastrointestinal Cancer Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Cancer Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Gastrointestinal Cancer Drugs Sales Share by Type (2015-2020)
Table 26. Global Gastrointestinal Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Gastrointestinal Cancer Drugs Revenue Share by Type (2015-2020)
Table 28. Gastrointestinal Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Gastrointestinal Cancer Drugs Sales Share by Type (2021-2026)
Table 30. Global Gastrointestinal Cancer Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Gastrointestinal Cancer Drugs Sales Share by Application (2015-2020)
Table 32. Global Gastrointestinal Cancer Drugs Sales Share by Application (2021-2026)
Table 33. Global Gastrointestinal Cancer Drugs Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Gastrointestinal Cancer Drugs Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Gastrointestinal Cancer Drugs Sales (K Units) of Key Companies (2015-2020)
Table 37. United States Gastrointestinal Cancer Drugs Sales Share by Company (2015-2020)
Table 38. United States Gastrointestinal Cancer Drugs Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Gastrointestinal Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 40. United States Gastrointestinal Cancer Drugs Sales Share by Type (2015-2020)
Table 41. United States Gastrointestinal Cancer Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Gastrointestinal Cancer Drugs Price (K Units) by Type (2015-2020)
Table 43. United States Gastrointestinal Cancer Drugs Sales (K Units) by Type (2021-2026)
Table 44. United States Gastrointestinal Cancer Drugs Sales Share by Type (2021-2026)
Table 45. United States Gastrointestinal Cancer Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Gastrointestinal Cancer Drugs Revenue Share by Type (2021-2026)
Table 47. United States Gastrointestinal Cancer Drugs Price (K Units) by Type (2021-2026)
Table 48. United States Gastrointestinal Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Gastrointestinal Cancer Drugs Sales Share by Application (2015-2020)
Table 50. United States Gastrointestinal Cancer Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Gastrointestinal Cancer Drugs Sales (K Units) by Application (2021-2026)
Table 52. United States Gastrointestinal Cancer Drugs Sales Share by Application (2021-2026)
Table 53. United States Gastrointestinal Cancer Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Gastrointestinal Cancer Drugs Revenue Share by Application (2021-2026)
Table 55. North America Gastrointestinal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 56. North America Gastrointestinal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 57. North America Gastrointestinal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 59. Europe Gastrointestinal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 60. Europe Gastrointestinal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 61. Europe Gastrointestinal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Gastrointestinal Cancer Drugs Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Gastrointestinal Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 67. Latin America Gastrointestinal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 68. Latin America Gastrointestinal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Gastrointestinal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Gastrointestinal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gastrointestinal Cancer Drugs Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Gastrointestinal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Gastrointestinal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Gastrointestinal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 75. Amgen & Amgen Ireland Corporation Information
Table 76. Amgen & Amgen Ireland Description and Business Overview
Table 77. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product
Table 79. Amgen & Amgen Ireland Recent Development
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Company Product
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Roche Product
Table 89. Roche Recent Development
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly and Company Product
Table 94. Eli Lilly and Company Recent Development
Table 95. Johnson & Johnson Private Corporation Information
Table 96. Johnson & Johnson Private Description and Business Overview
Table 97. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Private Product
Table 99. Johnson & Johnson Private Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Celgene Corporation Corporation Information
Table 106. Celgene Corporation Description and Business Overview
Table 107. Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Celgene Corporation Product
Table 109. Celgene Corporation Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Pfizer Product
Table 114. Pfizer Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Sanofi Product
Table 119. Sanofi Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Gastrointestinal Cancer Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Novartis Product
Table 124. Novartis Recent Development
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Gastrointestinal Cancer Drugs Players
Table 129. Gastrointestinal Cancer Drugs Customers List
Table 130. Gastrointestinal Cancer Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of FiguresFigure 1. Gastrointestinal Cancer Drugs Product Picture
Figure 2. Global Gastrointestinal Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oncology Product Picture
Figure 4. Radiology Product Picture
Figure 5. Others Product Picture
Figure 6. Global Gastrointestinal Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Specialized Cancer Treatment Centers
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Gastrointestinal Cancer Drugs Report Years Considered
Figure 12. Global Gastrointestinal Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastrointestinal Cancer Drugs Sales 2015-2026 (K Units)
Figure 14. Global Gastrointestinal Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastrointestinal Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Gastrointestinal Cancer Drugs Sales Market Share by Region in 2019
Figure 17. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastrointestinal Cancer Drugs Revenue Market Share by Region in 2019
Figure 19. Global Gastrointestinal Cancer Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Drugs Revenue in 2019
Figure 21. Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastrointestinal Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Gastrointestinal Cancer Drugs Sales Market Share by Type in 2019
Figure 24. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastrointestinal Cancer Drugs Revenue Market Share by Type in 2019
Figure 26. Global Gastrointestinal Cancer Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Gastrointestinal Cancer Drugs Sales Market Share by Application in 2019
Figure 29. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastrointestinal Cancer Drugs Revenue Market Share by Application in 2019
Figure 31. United States Gastrointestinal Cancer Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 32. United States Gastrointestinal Cancer Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. United States Gastrointestinal Cancer Drugs Market Share in Global Market 2015-2026
Figure 34. United States 5 and 10 Largest Gastrointestinal Cancer Drugs Players Market Share by Revenue in Gastrointestinal Cancer Drugs in 2019
Figure 35. United States Gastrointestinal Cancer Drugs Revenue Share by Type (2015-2020)
Figure 36. United States Gastrointestinal Cancer Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 37. United States Gastrointestinal Cancer Drugs Revenue Share by Application (2015-2020)
Figure 38. United States Gastrointestinal Cancer Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Gastrointestinal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Gastrointestinal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Gastrointestinal Cancer Drugs Sales Market Share by Country in 2019
Figure 42. North America Gastrointestinal Cancer Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Gastrointestinal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Gastrointestinal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Gastrointestinal Cancer Drugs Sales Market Share by Country in 2019
Figure 50. Europe Gastrointestinal Cancer Drugs Revenue Market Share by Country in 2019
Figure 51. Germany Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Gastrointestinal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Gastrointestinal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Gastrointestinal Cancer Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Gastrointestinal Cancer Drugs Revenue Market Share by Region in 2019
Figure 65. China Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Gastrointestinal Cancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Gastrointestinal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Gastrointestinal Cancer Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Gastrointestinal Cancer Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Gastrointestinal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Gastrointestinal Cancer Drugs Sales Growth Rate (2015-2020)